Skip to content
Home/Companies/MedTech/HighLife
HighLife

HighLife

MedTech·France·Active·11yr hold
Entry
2015
Hold
11yr
Status
Active

Who owns HighLife?

HighLife is a French MedTech company, currently owned by Sofinnova Partners since 2015.

Hand-verified · updated 2026-09-30

Open JSON · CC-BY
Sofinnova Partners
Investor
Sofinnova Partners
Sofinnova Capital VIII · 2015 · Life Sciences VC

Key facts

HQFrance
SectorMedTech
Websitewww.highlifemedical.com

More from Sofinnova Capital VIII

Other portfolio companies in the same fund.

VectivBio
Exited 2023
BiotechSwitzerland· 2017
to Ironwood Pharmaceuticals
Breath Therapeutics
Exited 2019
BiotechGermany· 2016
to Zambon
Corvidia Therapeutics
Exited 2020
BiotechUS· 2016
to Novo Nordisk
Delinia
Exited 2017
BiotechUK· 2016
to Celgene
ENYO Pharma
ENYO Pharma
Active
BiotechFrance· 2016
ReCor Medical
Exited 2018
MedTechUS· 2016
to Otsuka Holdings

More PE-backed in MedTech

Comparable medtech deals from other GPs.

Acufocus, Inc.
Exited 2023
The Carlyle GroupUS
to Bausch + Lomb
Adicon Holdings Limited
Active
The Carlyle GroupUS
Aesynt
Exited 2016
Francisco PartnersUS
to Omnicell
Alere Medical, Inc.
Active
TA AssociatesUS
Alma Lasers, Ltd.
Alma Lasers, Ltd.
Active
TA AssociatesIsrael
Amedes Group
Active
General AtlanticGermany

Questions

Who owns HighLife?

HighLife is currently owned by Sofinnova Partners, through Sofinnova Capital VIII, since 2015.

When did Sofinnova Partners acquire HighLife?

Sofinnova Partners acquired HighLife in 2015.

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue